Loading...
NPI 1265820179 · Tucson, AZ · General Acute Care Hospital
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Banner - University Medical Center Tucson Campus LLC is a general acute care hospital provider located in Tucson, Arizona. This profile covers 0 Medicare and 642 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Banner - University Medical Center Tucson Campus LLC |
| Address | 1625 N Campbell Ave |
| City | Tucson |
| State | AZ |
| ZIP | 85719 |
| Taxonomy | General Acute Care Hospital |
| NPI Enumerated | December 30, 2014 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $194.2M |
| Medicare | $0 |
BANNER - UNIVERSITY MEDICAL CENTER TUCSON CAMPUS LLC appears to be effectively single-payer in scope: there is no Medicare billing on file while reported Medicaid revenue is $194.2M. The absence of any Medicare revenue alongside large Medicaid receipts means payor concentration and operational exposure are heavily weighted to Medicaid.
Revenue concentration is high within a narrow set of emergency-department E/M codes: the top three Medicaid codes 99284 ($30.2M, 20.0%), 99285 ($27M, 17.8%), and 99283 ($18.9M, 12.5%) together account for 50.3% of the provider's total Medicaid revenue. This concentration indicates that a majority of Medicaid dollars derive from ED throughput and related acute evaluations rather than a broad mix of lower-revenue routine services.
The billing mix signals a high-volume emergency and acute-care operation: 99284 (74.4K claims) ranks #20 of 259 providers in-state (93th percentile; notably above typical state volume for this code), 99285 (55.7K claims) ranks #19 of 257 (93th percentile; typical, unremarkable volume), and observation and lower-level ED codes such as G0378 (37.4K claims) and 99282 (19.5K claims) appear among top codes. Together these counts and ranks point to heavy ED demand and substantial short-stay observation utilization as core service lines.
Oncology and high-cost infusion therapy are meaningful secondary revenue drivers: J9271 (pembrolizumab) accounts for $16.4M (10.8%) and ranks #2 of 6 providers in-state (80th percentile; typical, unremarkable volume), while other oncology-related injectables and biologics such as J9299, J9312, J9035, J2505, and Q5111 appear on the top-25 list. The presence of high-cost oncology drugs alongside IMRT codes (77301 and 77386) suggests an integrated cancer treatment capacity that contributes materially to Medicaid revenue.
Several specialty procedure and device lines show leading statewide positions: J1561 (immune globulin) ranks #1 of 6 providers in-state (100th percentile; notably above typical state volume) and 77301 and 77386 (IMRT-related) both rank #1 in-state (100th percentile; notably above typical state volume). These #1 rankings indicate the provider is a dominant in-state site for selected high-acuity, high-cost services despite a concentrated overall payer mix.
Imaging and diagnostic services are high-volume components of the revenue mix: 74177 (CT abdomen/pelvis with contrast) generated $10.7M (7.1%) on 17K claims and ranks #22 of 175 providers in-state (88th percentile), while 70450 (CT head without contrast) and 93306 (transthoracic echo) also contribute multi-million-dollar revenues. This pattern supports an operational footprint with robust radiology and advanced diagnostic capacity to support emergency and inpatient care.
Certain codes are statistical outliers in volume for the state: 96365 (initial IV infusion) is described as an "extreme outlier, far above typical state volume for this code" with 31.4K claims and $1.8M revenue (1.2%), and a very high claim count for 80053 (195.4K claims, $2.3M; ranks #4 of 196, 98th percentile) underscores extensive routine lab throughput. These outlier labels highlight areas where the provider’s utilization patterns diverge substantially from most in-state peers, likely reflecting procedural mix and site-of-care concentration.
The NPI tenure is long enough to have established service lines: the provider was enumerated on 2014-12-30 (~12 years ago). Given that timeline and the concentration of ED, oncology infusions, IMRT, and high-volume imaging, the organization appears to have built sustained, Medicaid-focused capabilities that make it a key in-state resource for acute, oncologic, and advanced procedural care.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
642 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 74,430 | $410 | $30.2M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 55,730 | $480 | $27M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 58,420 | $320 | $18.9M |
| J9271 | Injection, pembrolizumab, 1 mg | 1,920 | $8,550 | $16.4M |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 17,050 | $630 | $10.7M |
| 70450 | The provider performed computed tomography, or CT scanning, of the head or brain, without contrast. He performs the procedure to diagnose any brain or intracranial abnormalities. | 20,730 | $190 | $3.9M |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 1,970 | $1,750 | $3.4M |
| 77301 | Intensity modulated radiotherapy (IMRT) uses advanced computer technology to deliver very precise radiation beams that target and destroy the cancerous cells while avoiding the surrounding healthy… | 830 | $4,010 | $3.3M |
| 93306 | The provider uses transducers to obtain two–dimensional (2D) images of the heart structures through the chest wall. He evaluates the anatomy and function of all four heart chambers, valves, adjacent… | 9,090 | $330 | $3M |
| 43239 | The provider inserts a flexible endoscope through the mouth and down into the esophagus, stomach, and duodenum where he removes one or more tissue biopsy specimens for diagnostic analysis. | 4,650 | $640 | $3M |
Showing 1–10 of 642
How this provider's Medicaid billing volume and revenue compare to other Arizona providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arizona median
642 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 2 | 10 | 770 | $7,180 | $7.1M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 19 | 260 | 1,330 | $240 | $3.5M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 20 | 260 | 3,030 | $190 | $3.4M |
| J9306 | Injection, pertuzumab, 1 mg | 2 | 10 | 500 | $5,420 | $2.7M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 17 | 260 | 2,600 | $170 | $2.6M |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 22 | 180 | 1,490 | $320 | $2.2M |
| 44970 | Laparoscopy, surgical, appendectomy | 8 | 10 | 110 | $4,670 | $2.1M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 14 | 110 | 960 | $70 | $1.7M |
| J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | 2 | 10 | 410 | $1,540 | $1.6M |
| J9299 | Injection, nivolumab, 1 mg | 1 | 10 | 390 | $3,740 | $1.4M |
Showing 1–10 of 642
Other providers in the same ZIP code as Banner - University Medical Center Tucson Campus LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.